Policy

Policy

NAPWHA develops policy positions, briefings documents and submissions, working closely with member organisations and other Commonwealth funded peak bodies in the Blood Borne Virus (BBV) sector.

2020

In January 2020, NAPWHA provided a letter to the Australian Government Attorney Generals Department expressing deep concerns in the provisions of the ‘Religious Discrimination Bill 2019’ and how it prioritises the religious beliefs of healthcare workers over the healthcare needs of marginalised individuals and communities who are living with or at increased risk of HIV and who require sensitive and specialist health services.

In September 2020, NAPWHA and Living Positive Victoria submitted a recommendation to the legislature regarding the use of cannabis.

In November 2020, NAPWHA and Scarlet Alliance submitted feedback to the Office of the National Data Commissioner on the Data Availability and Transparency Bill 2020 Exposure Draft Consultation Paper with concerns over data sovereignty and consent.

In December 2020, NAPWHA was requested by Viiv Healthcare Australia to provide a community opinion to Clinical Director Prescription Medicines on the proposed registration of Cabenuva (Cabotegravir(CAB)+Rilpivirine(RPV) Long Acting (LA)) for the treatment of HIV. We have not been given any remuneration for the provision of this opinion.

2019

In September 2019, AFAO and NAPWHA provide a submission to the Royal Commission into Aged Care Quality and Safety asserting 5 key recommendations affecting the quality of life of people living with HIV in Australia and their potential challenges in aged care settings.

Submission to the Royal Commission into Aged Care Quality and Safety [PDF]
In September 2019, AFAO and NAPWHA provide a submission to the Royal Commission into Aged Care Quality and Safety asserting 5 key recommendations affecting the quality of life of people living with HIV in Australia and their potential challenges in aged care settings.

Submission to ICJ on the misuse of criminal law in the areas of sexuality, reproduction, drug use and HIV [PDF].  In March 2019, NAPWHA made a written submission to the ICJ (International Commission of Jurists) who made a call for inputs into the development of principles to address the detrimental impact on health, equality and human rights of criminalisation with a focus on sexuality, reproduction, drug use and HIV.

2018

NAPWHA advocated for best programs, services, outcomes and quality of life for PLHIV in Australia consulting with the Commonwealth to set new targets for PLHIV in the Eighth National HIV Strategy. This included urging the increase responses in HIV transmission among Aboriginal and Torres Strait Islander people and among heterosexuals.

2017

Submission to ASHM Australian Guidelines for HIV Positive Women and Breastfeeding [PDF]
In June 2017, the Femfatales provided a a submission on the Antiretroviral Guidelines US DHHS Guidelines with Australian commentary: HIV-Infected Women to the ASHM Sub-Committee for Guidance on HIV Management in Australia. The submission reviewed postpartum management and infant feeding, identifying that there are still important gaps in the existing evidence base and information about the risks and benefits. The Australian Guidelines for HIV Positive Women and Breastfeeding will be published by ASHM in late-2019.

 

Share This